[판매완료] Alma Legato II (2017년)

제조사 : Alma

제품명 : Legato II (레가또2)

제조년 : 2017년식

제품가 : 상담

담당자 : 박재범 이사 010-4252-4376

Legato II

Total Scars Solution
Legato II combines fractional ablation with Alma’s IMPACTTM skin barrier breakthrough solution to effectively treat scars, stretch marks and various skin imperfections- with minimal downtime.
The second-generation Legato II features interchangeable tips that allow practitioners to determine the precise level of ablation and thermal effect, while minimizing patient discomfort. IMPACT offers a breakthrough method of trans-epidermal delivery, allowing topical ingredients to penetrate the dermal-epidermal junction and reach deeper skin tissue for further treatment.
Legato II is appropriate for use on all skin types including dark and sensitive skin, making it an ideal method for scar removal and skin repair with excellent clinical outcomes.
Benefits:
• Combined technologies for optimal results
• Clinically proven treatment solution
• Minimal downtime
• Quick treatment
• Minimal downtime & Side Effects
• Suitable for all skin types

Technology

Microplasma™
Microplasma is a fractional ablative technology that can be used to improve skin imperfections while significantly reducing the risk of Post-Inflammatory Hyperpigmentation (PIH). Microplasma is a non-chromophore specific technology that both ablates and heats the skin through controlled, focused delivery of radio frequency energy without the need for expensive disposables.
IMPACT™
While fractional laser and RF treatments can be highly effective for a variety of indications, combining these with the application of active topical ingredients serves to maintain and significantly augment results.
Legato II’s IMPACT module offers a revolutionary skin barrier breakthrough solution that successfully delivers active ingredients beyond the epidermal–dermal junction. Once the skin is perforated via fractional microplasma, the Impact module emits acoustic waves and air pressure, pushing the topical compounds through the micro-channels. The acoustic vibrations create a push and pull effect within the channels, releasing the buildup of intra-cellular fluid and allowing the active ingredients to reach the targeted tissue depth. Histologies performed after the use of IMPACT technology have proven efficacy in advancing active ingredients to the deeper layers of the skin.
The synergy of fractional ablation and IMPACT technology offers a compound solution for maximally effective skin repair and aesthetic enhancement.
Treatment Process:
Legato II uses a 2-phase process to treat scar tissue and achieve effective trans-epidermal delivery of active compounds to the deeper skin layers.
Phase I Legato II begins with creating precisely disbursed micro-channels in the skin using microplasma technology. This creates a passage to the deeper layers of the skin. At the same time, the controlled thermal damage induced by the microplasma triggers a natural healing process that replaces disorganized, compacted scar tissue with healthy new collagen. The micro-channels are surrounded by untreated skin which also aids in rapid healing.
Phase II Once the skin is perforated, the IMPACT module uses ultrasound technology to advance topical compounds through the micro-channels, allowing their therapeutic properties to further treat damaged tissue at the dermal level.
Healing time is minimal, risk of infection or PIH (Post-Inflammatory Hyperpigmentation) is eliminated and little discomfort is felt.